All In Biotech

Free tool

FAERS Monitor: Odefsey

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208351 or its brand name (Odefsey, Emtricitabine, Rilpivirine Hydrochloride, Tenofovir Alafenamide Fumarate). Reports on generic versions are filed under their own applications.

Reports

3,596

Serious

2,736

76% of reports

Hospitalization

390

Death reported

72

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • bone density decreased1,605
  • chronic kidney disease874
  • tooth loss822
  • osteoporosis758
  • bone loss748
  • osteonecrosis713
  • pain711
  • emotional distress692
  • multiple fractures691
  • renal failure650
  • anxiety645
  • anhedonia604
  • osteopenia539
  • renal injury524
  • skeletal injury462

Reports by year received

View as table
YearReports
201652
2017119
2018224
2019379
20201,378
2021542
2022342
2023176
2024183
2025143
202658

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,563 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
bone density decreasedSignal1,605315.7303.9478,155
bone lossSignal748306.2286.7216,100
skeletal injurySignal462273.5250.6119,616
multiple fracturesSignal691256.8239.7168,543
tooth lossSignal822241.4227.0188,954
osteopeniaSignal539215.4198.9110,796
anhedoniaSignal604137.6127.879,970
osteonecrosisSignal713129.8121.489,135
osteoporosisSignal758109.8103.080,261
renal injurySignal524105.096.952,991
chronic kidney diseaseSignal87468.164.257,218
emotional distressSignal69233.631.421,869
renal failureSignal65028.826.817,417
anxietySignal64513.312.47,398
painSignal7116.86.33,596

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.